# Reliance Life Sciences Private Limited – FDA Inspection, Apr 15, 2022

Source: https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/25bd4384-4ea7-4998-8065-2fb38edb15d1
Source feed: FDA_Inspections

> FDA inspection 1170339 of Reliance Life Sciences Private Limited, April 15, 2022. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170339
- Company Name: Reliance Life Sciences Private Limited
- Inspection Date: 2022-04-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1311632 - 2026-02-27](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/ccab4917-175f-46db-ad0c-ba158ab3159d)
- FDA Inspection 1113122 - 2019-11-22
- [FDA Inspection 1081821 - 2019-02-22](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f95a3d58-e9f3-4080-8e57-56a6cf432d59)
- [FDA Inspection 1070144 - 2018-10-16](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f81e0521-c3a6-4bcf-9fb0-651407a13902)
- FDA Inspection 1047623 - 2018-01-25

Company: https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
